Standard

Uninephrectomized High-Fat-Fed Nicotinamide-Streptozotocin-Induced Diabetic Rats : A Model for the Investigation of Diabetic Nephropathy in Type 2 Diabetes. / Bayrasheva, Valentina K.; Babenko, Alina Yu; Dobronravov, Vladimir A.; Dmitriev, Yuri V.; Chefu, Svetlana G.; Pchelin, Ivan Yu; Ivanova, Alexandra N.; Bairamov, Alekber A.; Alexeyeva, Nina P.; Shatalov, Ivan S.; Grineva, Elena N.

в: Journal of Diabetes Research, Том 2016, № Article ID 8317850, 8317850, 2016.

Результаты исследований: Научные публикации в периодических изданияхстатьяРецензирование

Harvard

Bayrasheva, VK, Babenko, AY, Dobronravov, VA, Dmitriev, YV, Chefu, SG, Pchelin, IY, Ivanova, AN, Bairamov, AA, Alexeyeva, NP, Shatalov, IS & Grineva, EN 2016, 'Uninephrectomized High-Fat-Fed Nicotinamide-Streptozotocin-Induced Diabetic Rats: A Model for the Investigation of Diabetic Nephropathy in Type 2 Diabetes', Journal of Diabetes Research, Том. 2016, № Article ID 8317850, 8317850. https://doi.org/10.1155/2016/8317850, https://doi.org/10.1155/2016/8317850

APA

Bayrasheva, V. K., Babenko, A. Y., Dobronravov, V. A., Dmitriev, Y. V., Chefu, S. G., Pchelin, I. Y., Ivanova, A. N., Bairamov, A. A., Alexeyeva, N. P., Shatalov, I. S., & Grineva, E. N. (2016). Uninephrectomized High-Fat-Fed Nicotinamide-Streptozotocin-Induced Diabetic Rats: A Model for the Investigation of Diabetic Nephropathy in Type 2 Diabetes. Journal of Diabetes Research, 2016(Article ID 8317850), [8317850]. https://doi.org/10.1155/2016/8317850, https://doi.org/10.1155/2016/8317850

Vancouver

Author

Bayrasheva, Valentina K. ; Babenko, Alina Yu ; Dobronravov, Vladimir A. ; Dmitriev, Yuri V. ; Chefu, Svetlana G. ; Pchelin, Ivan Yu ; Ivanova, Alexandra N. ; Bairamov, Alekber A. ; Alexeyeva, Nina P. ; Shatalov, Ivan S. ; Grineva, Elena N. / Uninephrectomized High-Fat-Fed Nicotinamide-Streptozotocin-Induced Diabetic Rats : A Model for the Investigation of Diabetic Nephropathy in Type 2 Diabetes. в: Journal of Diabetes Research. 2016 ; Том 2016, № Article ID 8317850.

BibTeX

@article{62a732ad6c574b76bb4bcd07bca3a14c,
title = "Uninephrectomized High-Fat-Fed Nicotinamide-Streptozotocin-Induced Diabetic Rats: A Model for the Investigation of Diabetic Nephropathy in Type 2 Diabetes",
abstract = "Type 2 diabetes (DM2) could be reproduced in rats with alimentary obesity by using low doses of streptozotocin (LD-STZ) as well as STZ in high doses with preliminary nicotinamide (NA) administration. However, STZ could induce tubulotoxicity. Aim. To develop rat model of DN in NA-STZ-induced DM2 and compare it with LD-STZ-model in order to choose the most relevant approach for reproducing renal glomerular and tubular morphofunctional diabetic changes. Starting at 3 weeks after uninephrectomy, adult male Wistar rats were fed five-week high-fat diet and then received intraperitoneally either LD-STZ (40 mg/kg) or NA (230 mg/kg) followed by STZ (65 mg/kg). Control uninephrectomized vehicle-injected rats received normal chow. At weeks 10, 20, and 30 (the end of the study), metabolic parameters, creatinine clearance, albuminuria, and urinary tubular injury markers (NGAL, KIM-1) were evaluated as well as renal ultrastructural and light microscopic changes at weeks 20 and 30. NA-STZ-group showed higher reproducibility and stability of metabolic parameters. By week 10, in NA-STZ-group NGAL level was significantly lower compared to LD-STZ-group. By week 30, diabetic groups showed early features of DN. However, morphofunctional changes in NA-STZ-group appeared to be more pronounced than those in STZ-group despite lower levels of KIM-1 and NGAL. We proposed a new rat model of DM2 with DN characterized by stable metabolic disorders, typical renal lesions, and lower levels of tubular injury markers as compared to LD-STZ-induced diabetes.",
author = "Bayrasheva, {Valentina K.} and Babenko, {Alina Yu} and Dobronravov, {Vladimir A.} and Dmitriev, {Yuri V.} and Chefu, {Svetlana G.} and Pchelin, {Ivan Yu} and Ivanova, {Alexandra N.} and Bairamov, {Alekber A.} and Alexeyeva, {Nina P.} and Shatalov, {Ivan S.} and Grineva, {Elena N.}",
note = "Publisher Copyright: {\textcopyright} 2016 Valentina K. Bayrasheva et al.",
year = "2016",
doi = "10.1155/2016/8317850",
language = "English",
volume = "2016",
journal = "Journal of Diabetes Research",
issn = "2314-6745",
publisher = "Hindawi ",
number = "Article ID 8317850",

}

RIS

TY - JOUR

T1 - Uninephrectomized High-Fat-Fed Nicotinamide-Streptozotocin-Induced Diabetic Rats

T2 - A Model for the Investigation of Diabetic Nephropathy in Type 2 Diabetes

AU - Bayrasheva, Valentina K.

AU - Babenko, Alina Yu

AU - Dobronravov, Vladimir A.

AU - Dmitriev, Yuri V.

AU - Chefu, Svetlana G.

AU - Pchelin, Ivan Yu

AU - Ivanova, Alexandra N.

AU - Bairamov, Alekber A.

AU - Alexeyeva, Nina P.

AU - Shatalov, Ivan S.

AU - Grineva, Elena N.

N1 - Publisher Copyright: © 2016 Valentina K. Bayrasheva et al.

PY - 2016

Y1 - 2016

N2 - Type 2 diabetes (DM2) could be reproduced in rats with alimentary obesity by using low doses of streptozotocin (LD-STZ) as well as STZ in high doses with preliminary nicotinamide (NA) administration. However, STZ could induce tubulotoxicity. Aim. To develop rat model of DN in NA-STZ-induced DM2 and compare it with LD-STZ-model in order to choose the most relevant approach for reproducing renal glomerular and tubular morphofunctional diabetic changes. Starting at 3 weeks after uninephrectomy, adult male Wistar rats were fed five-week high-fat diet and then received intraperitoneally either LD-STZ (40 mg/kg) or NA (230 mg/kg) followed by STZ (65 mg/kg). Control uninephrectomized vehicle-injected rats received normal chow. At weeks 10, 20, and 30 (the end of the study), metabolic parameters, creatinine clearance, albuminuria, and urinary tubular injury markers (NGAL, KIM-1) were evaluated as well as renal ultrastructural and light microscopic changes at weeks 20 and 30. NA-STZ-group showed higher reproducibility and stability of metabolic parameters. By week 10, in NA-STZ-group NGAL level was significantly lower compared to LD-STZ-group. By week 30, diabetic groups showed early features of DN. However, morphofunctional changes in NA-STZ-group appeared to be more pronounced than those in STZ-group despite lower levels of KIM-1 and NGAL. We proposed a new rat model of DM2 with DN characterized by stable metabolic disorders, typical renal lesions, and lower levels of tubular injury markers as compared to LD-STZ-induced diabetes.

AB - Type 2 diabetes (DM2) could be reproduced in rats with alimentary obesity by using low doses of streptozotocin (LD-STZ) as well as STZ in high doses with preliminary nicotinamide (NA) administration. However, STZ could induce tubulotoxicity. Aim. To develop rat model of DN in NA-STZ-induced DM2 and compare it with LD-STZ-model in order to choose the most relevant approach for reproducing renal glomerular and tubular morphofunctional diabetic changes. Starting at 3 weeks after uninephrectomy, adult male Wistar rats were fed five-week high-fat diet and then received intraperitoneally either LD-STZ (40 mg/kg) or NA (230 mg/kg) followed by STZ (65 mg/kg). Control uninephrectomized vehicle-injected rats received normal chow. At weeks 10, 20, and 30 (the end of the study), metabolic parameters, creatinine clearance, albuminuria, and urinary tubular injury markers (NGAL, KIM-1) were evaluated as well as renal ultrastructural and light microscopic changes at weeks 20 and 30. NA-STZ-group showed higher reproducibility and stability of metabolic parameters. By week 10, in NA-STZ-group NGAL level was significantly lower compared to LD-STZ-group. By week 30, diabetic groups showed early features of DN. However, morphofunctional changes in NA-STZ-group appeared to be more pronounced than those in STZ-group despite lower levels of KIM-1 and NGAL. We proposed a new rat model of DM2 with DN characterized by stable metabolic disorders, typical renal lesions, and lower levels of tubular injury markers as compared to LD-STZ-induced diabetes.

UR - http://www.scopus.com/inward/record.url?scp=85008873178&partnerID=8YFLogxK

U2 - 10.1155/2016/8317850

DO - 10.1155/2016/8317850

M3 - Article

C2 - 28090542

VL - 2016

JO - Journal of Diabetes Research

JF - Journal of Diabetes Research

SN - 2314-6745

IS - Article ID 8317850

M1 - 8317850

ER -

ID: 7642817